Journal article
Alterations of plasma lipid and lipoprotein levels associated with benzodiazepine use The LRC program prevalence study
Atherosclerosis, Vol.40(2), pp.159-165
1981
DOI: 10.1016/0021-9150(81)90034-4
PMID: 6118165
Abstract
In a study of white adults from 10 North American Lipid Research Clinics populations, plasma lipid and lipoprotein levels in benzodiazepine (diazepam, chlordiazepoxide, flurazepam) users were compared to both the entire population of non-users and matched control non-users. Significantly higher plasma triglyceride and very low density lipoprotein cholesterol levels and by one method of analysis, lower high density lipoprotein cholesterol levels were noted in male benzodiazepine users. No significant differences were noted in total plasma cholesterol or low density lipoprotein cholesterol levels.
Details
- Title: Subtitle
- Alterations of plasma lipid and lipoprotein levels associated with benzodiazepine use The LRC program prevalence study
- Creators
- Donald Hunninghake - University of MinnesotaRobert B. Wallace - University of IowaSusan Reiland - University of North Carolina at Chapel HillElizabeth Barrett-Connor - University of California San DiegoPatricia Wahl - University of WashingtonJoanne Hoover - University of WashingtonGerardo Heiss - University of North Carolina at Chapel HillMedication and hormones working group
- Resource Type
- Journal article
- Publication Details
- Atherosclerosis, Vol.40(2), pp.159-165
- DOI
- 10.1016/0021-9150(81)90034-4
- PMID
- 6118165
- NLM abbreviation
- Atherosclerosis
- ISSN
- 0021-9150
- eISSN
- 1879-1484
- Publisher
- Elsevier Ireland Ltd
- Language
- English
- Date published
- 1981
- Academic Unit
- Epidemiology; Injury Prevention Research Center; Internal Medicine
- Record Identifier
- 9984363625902771
Metrics
30 Record Views